Innovation Pharmaceuticals Inc (IPIX)

[noretreat]

The drop to 1.40 last year, in my opinion, was largely from the sale of shares used to buy PolyMedix' assets, along with some folks jumping off the bandwagon to protect their earlier gains. Importantly, the drop came with relatively low volume, demonstrating the fragile nature of CTIX' share price. It was a great buying opportunity for the nimble.

The same type of elastic share price should work to the upside.

Today should be the cross, by the way.

I note that the five big spikes in sp over the last 2 years have all been accompanied by high volume, so without a nice volume bump it is unlikely that the highs will be challenged. Nevertheless, we could get another dime or two out of the cross and the progressing trials.

Will it hold? You decide.